ANDA 71727, held by Gd Searle LLC. Clorazepate Dipotassium.
As of Nov 16, 2026, ANDA 71727 (Clorazepate Dipotassium), held by Gd Searle LLC, was first approved by FDA on Dec 18, 1987, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 18, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clorazepate Dipotassium3.75MG ยท capsule;oral | Clorazepate Dipotassium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters